Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers

Annals of Oncology - Tập 29 - Trang 2223-2231 - 2018
D. Głodzik1,2, C. Purdie3, I.H. Rye4, P.T. Simpson5, J. Staaf1, P.N. Span6, H.G. Russnes4,7, S. Nik-Zainal2,8
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden
2Wellcome Trust Sanger Institute, Hinxton, Cambridge
3Department of Pathology, Ninewells Hospital & Medical School, Dundee, UK
4Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
5Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
6Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
7Department of Pathology, Oslo University Hospital, Oslo, Norway
8Academic Department of Medical Genetics, The Clinical School University of Cambridge, Cambridge, UK

Tài liệu tham khảo

Ching, 2011, Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array, Int J Oncol, 39, 621 Fang, 2011, Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis, Cancer, 117, 2024, 10.1002/cncr.25770 King, 1985, Amplification of a novel v-erbB-related gene in a human mammary carcinoma, Science, 229, 974, 10.1126/science.2992089 Cairns, 1995, Frequency of homozygous deletion at p16/CDKN2 in primary human tumours, Nat Genet, 11, 210, 10.1038/ng1095-210 Nik-Zainal, 2016, Landscape of somatic mutations in 560 breast cancer whole-genome sequences, Nature, 534, 47, 10.1038/nature17676 Drier, 2013, Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability, Genome Res, 23, 228, 10.1101/gr.141382.112 Willis, 2015, Deciphering the Code of the Cancer Genome: mechanisms of Chromosome Rearrangement, Trends Cancer, 1, 217, 10.1016/j.trecan.2015.10.007 Euhus, 2002, ETV6-NTRK3–Trk-ing the primary event in human secretory breast cancer, Cancer Cell, 2, 347, 10.1016/S1535-6108(02)00184-8 Salagierski, 2012, Molecular diagnosis of prostate cancer: pCA3 and TMPRSS2: eRG gene fusion, J Urol, 187, 795, 10.1016/j.juro.2011.10.133 Stephens, 2011, Massive genomic rearrangement acquired in a single catastrophic event during cancer development, Cell, 144, 27, 10.1016/j.cell.2010.11.055 Baca, 2013, Punctuated evolution of prostate cancer genomes, Cell, 153, 666, 10.1016/j.cell.2013.03.021 Ferrari, 2016, A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers, Nat Commun, 7, 12222, 10.1038/ncomms12222 Nilsson, 2008, An improved method for detecting and delineating genomic regions with altered gene expression in cancer, Genome Biol, 9, R13., 10.1186/gb-2008-9-1-r13 Bautista, 1998, CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei, Genes Chromosomes Cancer, 22, 268, 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.0.CO;2-T Paterson, 2007, Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event, Genes Chromosom Cancer, 46, 427, 10.1002/gcc.20424 PCAWG-Structural Variation Working Group, 2018, t.P.N., Selective and mechanistic sources of recurrent rearrangements across the cancer genome, bioRxiv